Pharmacology & Chemical Biology
University of Pittsburgh, USA
Dr Dong Xiao is currently working as a Research Assistant Professor in the Department of Pharmacology Chemical Biology and University of Pittsburgh Cancer Institute at University of Pittsburgh. His laboratory focuses on the study of some dietary natural products on the effects and biomarkers of their prevention/therapy of prostate and breast cancers. Their field of expertise is chemoprevention and the inhibition of cancer cell growth through the modulation of genes that are associated with cell cycle autophagy and apoptosis His work is funded by the National Institute of Health .He is also an Associate Editor of Frontiers in Pharmacology of Natural Products and reviewer for national and international journals in his field and he has authored or coauthored more than 60 primary papers published in peerreviewed journals such as Cancer Research Journal of Biological Chemistry Oncogene Molecular Cancer Therapeutics and Clinical Cancer Research.
Our field of expertise is chemoprevention and the inhibition of cancer cell growth through the modulation of genes that are associated with cell cycle, autophagy and apoptosis. The long-term goal of Dr. Xiao’s research is to develop a safe and effective strategy for chemoprevention/chemotherapy of the human prostate and breast cancer.